Kenya: 'Availability of Lenacapavir Treatment in 2025 Set to Transform Global Health,' Says CDC Kenya's Director

[Capital FM] Kisii — The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the completion of phase 3 trial of lenacapavir treatment.



Source link : https://allafrica.com/stories/202410230160.html

Author :

Publish date : 2024-10-23 09:54:08

Copyright for syndicated content belongs to the linked Source.